Allegra Orthopaedics Ltd (AMT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Allegra Orthopaedics Ltd (AMT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013813
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥73,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥109,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Allegra Orthopaedics Ltd (Allegra), develops, manufactures and sells prosthetic implants and related orthopedic medical devices. Its major products include adult and adolescent clavicle fixation system and pin; shoulder implants; proximal humeral plates; trauma distal radial plates and systems; hand fracture plates and ulna heads; PIPR and TMPR replacement products; hip stems and heads; fixion femoral nail systems; total knee replacement systems; fixion tibial nail systems; distal fibular plates; ankle, hind/mid foot and toes, K-wires, pins, surgical blades and ACL screws; and RYU casts and splints. Allegra also provides integrated services to surgeons and hospitals. It offers manufacturing services such as instrument manufacturing and precision manufacturing to other companies. The company offers its products Australia, Europe and the US. Allegra is headquartered in New South Wales, Australia.

Allegra Orthopaedics Ltd (AMT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Allegra Orthopaedics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Allegra Orthopaedics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Allegra Orthopaedics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Allegra Orthopaedics Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Allegra Orthopaedics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Allegra Orthopaedics Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Advanced Surgical Design Enters Into Licensing Agreement With University Of Sydney 10
Advanced Surgical Design and Manufacture Enters Into Distribution Agreement Orthofix Spinal Implants 11
Equity Offering 12
Allegra Orthopaedics Raises USD1 Million in Private Placement of Shares 12
Allegra Orthopaedics Raises USD0.4 Million in Second Tranche of Private Placement of Shares 13
Allegra Orthopaedics Raises USD0.6 Million in First Tranche of Private Placement of Shares 14
Allegra Orthopaedics to Raise USD1 Million in Rights Offering of Shares 15
Advanced Surgical Completes Rights Offering of Shares For US$0.25 Million 16
Allegra Orthopaedics Ltd – Key Competitors 17
Allegra Orthopaedics Ltd – Key Employees 18
Allegra Orthopaedics Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Oct 31, 2016: Allegra Orthopaedics: Financial Results for Q1 FY2017 20
Corporate Communications 21
Apr 20, 2016: Allegra Orthopaedics Announces Management Changes 21
Product News 22
02/04/2016: Allegra Orthopaedics Announces Update On Outsourcing Of Manfacturing 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Allegra Orthopaedics Ltd, Medical Equipment, Key Facts, 2017 2
Allegra Orthopaedics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Allegra Orthopaedics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Allegra Orthopaedics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Allegra Orthopaedics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Allegra Orthopaedics Ltd, Deals By Market, 2011 to YTD 2017 8
Allegra Orthopaedics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Advanced Surgical Design Enters Into Licensing Agreement With University Of Sydney 10
Advanced Surgical Design and Manufacture Enters Into Distribution Agreement Orthofix Spinal Implants 11
Allegra Orthopaedics Raises USD1 Million in Private Placement of Shares 12
Allegra Orthopaedics Raises USD0.4 Million in Second Tranche of Private Placement of Shares 13
Allegra Orthopaedics Raises USD0.6 Million in First Tranche of Private Placement of Shares 14
Allegra Orthopaedics to Raise USD1 Million in Rights Offering of Shares 15
Advanced Surgical Completes Rights Offering of Shares For US$0.25 Million 16
Allegra Orthopaedics Ltd, Key Competitors 17
Allegra Orthopaedics Ltd, Key Employees 18
Allegra Orthopaedics Ltd, Subsidiaries 19

★海外企業調査レポート[Allegra Orthopaedics Ltd (AMT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Turner & Townsend Plc:企業の戦略的SWOT分析
    Turner & Townsend Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • LivaNova PLC (LIVN):企業の製品パイプライン分析2018
    Summary LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depressio …
  • Airbus SE (AIR):企業の財務・戦略的SWOT分析
    Airbus SE (AIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Rural Areas Electricity Company SAO.C.:企業の戦略的SWOT分析
    Rural Areas Electricity Company SAO.C. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Cerus Corp (CERS):医療機器:M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Leukocare AG-製薬・医療分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • Provectus Biopharmaceuticals Inc (PVCT):企業の財務・戦略的SWOT分析
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Smurfit Kappa Group plc:企業のM&A・事業提携・投資動向
    Smurfit Kappa Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smurfit Kappa Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Renesola Ltd (SOL):電力:M&Aディール及び事業提携情報
    Summary Renesola Ltd (ReneSola) is a solar project developer and operator of energy efficient products that manufactures polysilicon, monocrystalline and multi crystalline solar wafers; and solar photovoltaic cells and modules. It also develops, builds and sells solar power projects across Europe, N …
  • Movenpick Schweiz AG:企業の戦略・SWOT・財務情報
    Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report Summary Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析
    Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Zotefoams plc (ZTF):企業の財務・戦略的SWOT分析
    Summary Zotefoams plc (Zotefoams) is a chemical manufacturer that markets cross-linked block foams. The company offers products such as microzote, zotek F, zotek N, T tubes, plastazote, evazote, zotek peba foam, supazote, and others. It offers services such as manufacturing and distribution services …
  • Denbury Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Denbury Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Denbury Resources Inc (Denbury) is an independent oil and natural gas company. It carries out exploration, development and production of oil and natural gas from its assets in the Gulf Coast an …
  • Alps Electric Co., Ltd.:企業の戦略・SWOT・財務分析
    Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • AxoGen Inc (AXGN):企業の財務・戦略的SWOT分析
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among …
  • Jack in the Box Inc (JACK):企業の財務・戦略的SWOT分析
    Jack in the Box Inc (JACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • eClinicalWorks LLC:企業の戦略的SWOT分析
    eClinicalWorks LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Actuate Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actuate Therapeutics Inc (Actuate Therapeutics) is a biopharmaceutical company that offers development of novel compounds for the treatment of cancer and inflammatory diseases. The company’s lead compound 9-ING-41 is under evaluation for anti-tumor activity in various vivo models. It also de …
  • Lannett Company Inc (LCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Lannett Company Inc (Lannett) is a pharmaceutical company. It develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms. The company offers generic pharmaceuticals for medical indications such as antibiotic, cardiovascular, c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆